Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2011-05-10
Original market date: See footnote 1
1996-02-02
Product name:
RENAMIN (AMINO ACIDS) INJECTION
DIN:
02020564 Electronic product monograph is not available
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
15
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA01 AMINO ACIDS
Active ingredient group (AIG) number:See footnote5
1550855001
Active ingredient(s) See footnote8 | Strength |
---|---|
GLYCINE | 300 MG / 100 ML |
HISTIDINE | 420 MG / 100 ML |
L-ALANINE | 560 MG / 100 ML |
L-ARGININE | 630 MG / 100 ML |
L-ISOLEUCINE | 500 MG / 100 ML |
L-LEUCINE | 600 MG / 100 ML |
L-LYSINE HYDROCHLORIDE | 450 MG / 100 ML |
L-PHENYLALANINE | 490 MG / 100 ML |
L-PROLINE | 350 MG / 100 ML |
L-THREONINE | 380 MG / 100 ML |
L-TYROSINE | 40 MG / 100 ML |
L-VALINE | 820 MG / 100 ML |
METHIONINE | 500 MG / 100 ML |
SERINE | 300 MG / 100 ML |
TRYPTOPHAN | 160 MG / 100 ML |